KR890002402A - 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 - Google Patents

인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 Download PDF

Info

Publication number
KR890002402A
KR890002402A KR1019880008579A KR880008579A KR890002402A KR 890002402 A KR890002402 A KR 890002402A KR 1019880008579 A KR1019880008579 A KR 1019880008579A KR 880008579 A KR880008579 A KR 880008579A KR 890002402 A KR890002402 A KR 890002402A
Authority
KR
South Korea
Prior art keywords
dna
protein
hpv
proteins encoded
human papillomavirus
Prior art date
Application number
KR1019880008579A
Other languages
English (en)
Other versions
KR970005047B1 (ko
Inventor
그림멜 마르기타
데 빌리어스 에텔-미켈레
Original Assignee
필립 스타인
베링베르케 아크티엔게젤샤프트
헤리베르트 부크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 필립 스타인, 베링베르케 아크티엔게젤샤프트, 헤리베르트 부크 filed Critical 필립 스타인
Publication of KR890002402A publication Critical patent/KR890002402A/ko
Application granted granted Critical
Publication of KR970005047B1 publication Critical patent/KR970005047B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

인간의 유두종바이러스 형41, 이의 DNA 및 이로부터 코드화된 단백질
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 제한 효소분해에 대한 물리적 게놈(genome)도표.
제2도는 HPV 41과 HPV 8의 상결성(colinearitg)을 나타낸 도표.

Claims (12)

  1. 클론 K10 및 K6을 특징으로 하는 HPV 41 DNA.
  2. 유전공학으로 수득가능한 HPV 41의 발현생성물(단백질).
  3. 항체를 제조하기 위한 제2항에 따른 발현생성물(단밸직)의 용도.
  4. HPV 41의 발현생성물에 대한 모노-또는 폴리클로널 항체.
  5. 제4항에 따른 항체를 함유하는 진단용 제제(diagnostic).
  6. 생검 또는 도말표본 물질을 제5항에 따른 진단용제제와 접촉시킴을 특징으로하여, HPV 41감염을 진단하는 방법.
  7. 단백질의 유전 공학적 제조에 사용하기 위한 제2항에 따른 단백질을 코드화하는 DNA의 용도.
  8. HPV 41감염을 진단하기 위한 제2항에 따른 단백질을 코드화하는 DNA 또는 이의 일부의 용도.
  9. 제2항에 따른 단백질을 코드화하는 DNA 또는 이 DNA의 일부를 함유하는 진단용제제.
  10. 연구중인 RNA 또는 DNA를, 제2항에 따른 단백질 또는 이 단백질의 일부를 코드화하는 DNA와 하이브리드화시킴(hybridizing)을 특징으로하여, HPV 41감염을 진단하는 방법.
  11. 예방접종 및 치료에 사용하기 위한 제2항에 따른 생성물의 용도.
  12. 예방 및 치료에 사용하기 위한 제1항에 따른 생성물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880008579A 1987-07-11 1988-07-11 사람의 유두종 바이러스 타입 41, 이의 dna 및 이로부터 암호화된 단백질 KR970005047B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3722968.0 1987-07-11
DE19873722968 DE3722968A1 (de) 1987-07-11 1987-07-11 Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine

Publications (2)

Publication Number Publication Date
KR890002402A true KR890002402A (ko) 1989-04-10
KR970005047B1 KR970005047B1 (ko) 1997-04-11

Family

ID=6331386

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880008579A KR970005047B1 (ko) 1987-07-11 1988-07-11 사람의 유두종 바이러스 타입 41, 이의 dna 및 이로부터 암호화된 단백질

Country Status (12)

Country Link
US (2) US5142032A (ko)
EP (1) EP0301289B1 (ko)
JP (1) JP2746380B2 (ko)
KR (1) KR970005047B1 (ko)
AT (1) ATE111158T1 (ko)
AU (1) AU617330B2 (ko)
CA (1) CA1340322C (ko)
DE (2) DE3722968A1 (ko)
DK (1) DK173259B1 (ko)
ES (1) ES2060625T3 (ko)
FI (1) FI100538B (ko)
PT (1) PT87940B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1314431E (pt) * 1993-04-30 2008-10-24 Wellstat Biologics Corp Composições purificadas de vírus da doença de newcastle
DE19526386C1 (de) 1995-07-19 1997-01-02 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
EP1169480A4 (en) * 1999-04-14 2005-02-02 Musc Found For Res Dev TISSUE-SPECIFIC AND PATHOGENIC TOXIC SUBSTANCES AND RIBOZYMES
US20030059806A1 (en) * 2001-01-05 2003-03-27 Science & Technology Corporation @ Unm Probes for the detection of human papillomavirus
JP2005537028A (ja) * 2002-06-26 2005-12-08 ザ　ペン　ステート　リサーチ　ファウンデーション ヒト乳頭腫ウイルス感染症を治療する方法及び材料
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005816A1 (en) * 1985-04-04 1986-10-09 Georgetown University Type-specific papillomavirus dna sequences and peptides
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
DE3722967A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung
DE3826793A1 (de) * 1988-08-06 1990-03-08 Behringwerke Ag Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine

Also Published As

Publication number Publication date
DE3722968A1 (de) 1989-01-19
DK383488D0 (da) 1988-07-08
FI100538B (fi) 1997-12-31
DE3851391D1 (de) 1994-10-13
PT87940B (pt) 1995-03-01
KR970005047B1 (ko) 1997-04-11
ES2060625T3 (es) 1994-12-01
JP2746380B2 (ja) 1998-05-06
EP0301289A1 (de) 1989-02-01
ATE111158T1 (de) 1994-09-15
AU1887888A (en) 1989-04-20
EP0301289B1 (de) 1994-09-07
PT87940A (pt) 1989-06-30
FI883255A (fi) 1989-01-12
JPS6455182A (en) 1989-03-02
DK383488A (da) 1989-01-12
US5142032A (en) 1992-08-25
US5382509A (en) 1995-01-17
FI883255A0 (fi) 1988-07-07
DK173259B1 (da) 2000-05-29
CA1340322C (en) 1999-01-19
AU617330B2 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
FI860015A (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
ATE112310T1 (de) Hemmung von htlv-iii durch exogene oligonukleotide.
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
PT83255B (pt) Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus
RU2218181C2 (ru) ЧЕЛОВЕЧЕСКИЙ СЕМАФОРИН L(H-Sema-L) И СООТВЕТСТВУЮЩИЕ СЕМАФОРИНЫ В ДРУГИХ ВИДАХ
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
KR890002402A (ko) 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질
EP0248534A3 (en) Method of detecting aids virus infection
KR890008317A (ko) 유전학적 조작에 의한 응고억제성 단백질 pp4의 제조방법
JPH01503436A (ja) 少数ライノウイルスレセプターグループのレセプター
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
KR890013181A (ko) 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법
MÜLLER-EBERHARD Biochemistry of complement
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
KR890008316A (ko) 항응고성 단백질 pp4-x, 및 이의 제조방법 및 용도
RU94044991A (ru) Способ получения иммуносорбента для иммунодиагностики вирусного гепатита с
Kozikowski et al. Interferon induction by the psittacosis agent in guinea pig leukocyte cultures
KR900009987A (ko) 태반 단백질 11(PP11)을 암호화하는 cDNA, 이의 분리방법 및 용도
Wood et al. Precipitin reaction obtainable between human serum and extracts of group A, type 15 streptococci.
Bukrinskaia et al. Rapid diagnosis of rotavirus infections by RNA electrophoresis on polyacrylamide gel
Dimitrova-Diminarova et al. Establishment of B cell line producing human antisperm antibodies by Epstein-Barr virus transformation of peripheral blood lymphocytes from infertile women with sperm immobilizing antibodies
Ivanova et al. NOTES ON THE ROLE PLAYED BY MICROBIOLOGICAL FACTORS IN THE OCCURRENCE AND COURSE OF SCHIZOPHRENIA
Dick Microbiology and Monoclonal Antibodies: A New Key to Diagnosis and Therapy
Marr Studies on the processing of the structural and nonstructural proteins of rubella virus.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050830

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee